Abstract: The present invention relates to 1,2,4-oxadiazoles azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Type:
Application
Filed:
September 30, 2013
Publication date:
April 10, 2014
Applicant:
Alergan, Inc.
Inventors:
Janet A. Takeuchi, Ling Li, Wha-Bin Im, Ken Chow